CIK 0001422142
- Non-accelerated filer
- Smaller reporting company
Whitehawk Therapeutics, Inc.
Sign in to watch- Ticker
- WHWK
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 611547850
- Phone
- +1 551-321-2234
- Business address
- 2 HEADQUARTERS PLAZA, EAST BUILDING, 11TH FLOOR, MORRISTOWN, NJ, 07960
- Former names
- Aadi Bioscience, Inc., Aerpio Pharmaceuticals, Inc., ZETA ACQUISITION CORP II
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Planned sale Executive Chairman sold 42,000 shares at $1.74 ($73,269)
- 4 Open-market sale Executive Chairman sold 42,000 shares at $2.06 ($86,549)
- 4 Open-market sale Executive Chairman sold 7,037 shares at $4.82 ($33,914)
- 4 Open-market sale Executive Chairman sold 34,963 shares at an average $5.09 ($177,808)
- 4 Open-market sale Executive Chairman sold 42,000 shares at an average $4.42 ($185,750)
- 4 Open-market sale Executive Chairman sold 42,000 shares at an average $4.26 ($179,001)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Executive Chairman sold 42,000 shares at an average $5.69 ($238,826)
- 4 Open-market sale Executive Chairman sold 42,000 shares at an average $5.21 ($218,774)
- 4 Open-market sale Executive Chairman sold 42,000 shares at an average $6.47 ($271,592)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Executive Chairman sold 7,260 shares at $8.19 ($59,453)
Page 5 of 14 · 263 filings